Antibody camera: new imaging study tracks cancer fighters in real time
NCT ID NCT02307630
First seen Dec 12, 2025 · Last updated May 06, 2026 · Updated 18 times
Summary
This study uses a radioactive antibody (124I-Hu3F8) and PET/CT scans to see how the antibody moves through the body and reaches tumors. Seven people with melanoma, neuroblastoma, or sarcoma will receive one injection and have multiple scans over several days. The goal is to understand the antibody's behavior, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.